Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input.
D000679:Amygdala / Q000187:drug effects*; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D002934:Cinnamates / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D003988:Dibenzothiepins / Q000494:pharmacology; D004873:Ergolines / Q000494:pharmacology; D005829:Geniculate Bodies / Q000187:drug effects*; D006624:Hippocampus / Q000166:cytology; D007478:Iontophoresis; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects*; D008784:Methysergide / Q000494:pharmacology; D008845:Microinjections; D009433:Neural Inhibition / Q000187:drug effects; D009474:Neurons / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D013440:Sulfides / Q000494:pharmacology; D013477:Superior Colliculi / Q000187:drug effects*; D013569:Synapses / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects
D000813:Anilides; D002934:Cinnamates; D003988:Dibenzothiepins; D004873:Ergolines; D010879:Piperazines; D012702:Serotonin Antagonists; D013440:Sulfides; D003533:Cyproheptadine; D012701:Serotonin; D008784:Methysergide